HER-2 Positive Breast Cancer Course
Date: 15 November 2021
Venue: Online course
This event was kindly supported by an unrestricted educational grant from Seagen, and who had no input into the content and agenda
The field of breast cancer is ever advancing, with more and more treatments becoming available, resulting in better outcomes for our patients. The management of HER2 positive breast cancer in particular has taken tremendous strides over the last year or so. On this course we aim to discuss the evidence behind why we manage HER2 positive breast cancer the way we do in both the early and metastatic settings.
We also invite delegates to submit or present any challenging cases they have encountered in their own practice to reflect and share their learning with others.
- To learn about the management of early breast cancer
- To learn about the management of metastatic breast cancer, paying particular notice to the challenging area of brain metastases
- To reflect on any difficult cases you may have come across and discuss on their management